Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Descriptor ID |
D029424
|
| MeSH Number(s) |
C08.381.495.389
|
| Concept/Terms |
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in this website by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 5 | 1 | 6 |
| 2004 | 2 | 0 | 2 |
| 2005 | 9 | 3 | 12 |
| 2006 | 8 | 0 | 8 |
| 2007 | 12 | 3 | 15 |
| 2008 | 15 | 2 | 17 |
| 2009 | 8 | 2 | 10 |
| 2010 | 13 | 3 | 16 |
| 2011 | 23 | 1 | 24 |
| 2012 | 15 | 2 | 17 |
| 2013 | 17 | 5 | 22 |
| 2014 | 7 | 4 | 11 |
| 2015 | 17 | 1 | 18 |
| 2016 | 20 | 7 | 27 |
| 2017 | 23 | 2 | 25 |
| 2018 | 34 | 2 | 36 |
| 2019 | 14 | 4 | 18 |
| 2020 | 17 | 3 | 20 |
| 2021 | 16 | 3 | 19 |
| 2022 | 35 | 0 | 35 |
| 2023 | 26 | 0 | 26 |
| 2024 | 18 | 4 | 22 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort. Front Immunol. 2025; 16:1508786.
-
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores. Respir Med. 2025 May; 241:108015.
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.
-
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease. Mol Ther. 2025 Mar 05; 33(3):917-932.
-
Sialidase fusion protein protects against influenza infection in a cigarette smoke-induced model of COPD. Mucosal Immunol. 2025 Apr; 18(2):467-480.
-
Oxidative stress promotes lipid-laden macrophage formation via CYP1B1. Redox Biol. 2025 Feb; 79:103481.
-
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. Am J Respir Crit Care Med. 2024 Dec 15; 210(12):1453-1460.
-
The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD. Chest. 2025 May; 167(5):1346-1355.
-
Lung Tissue Multilayer Network Analysis Uncovers the Molecular Heterogeneity of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1219-1229.
-
Access to Treatment for Chronic Obstructive Pulmonary Disease in the Americas: A Call for Action. A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and the American Thoracic Society. Ann Am Thorac Soc. 2024 Nov; 21(11):1463-1470.